This article, co-authored with Noel O’Boyle and Roger Sayle of Optibrium NextMove Software, was published in Drug Discovery World.
It discusses how matched series analysis goes beyond matched molecular pairs to identify more relevant chemical substitutions with which to improve target potency.
Summary
In lead optimisation, the goal is to improve activity, physicochemical and ADME properties by making stepwise alterations to a compound. One method commonly used is matched molecular pair analysis, however, it doesn’t always deliver on potency.
In this article, the authors discuss an extension of the matched pairs method, matched series analysis, which involves more than two R-groups. They demonstrate the benefits of this method around improving potency whilst still being guided by experimental data.
Find out more
Read the article via the button above, or learn more about matched series analysis by checking out some of our other resources:
- Article: Practical Applications of Matched Series Analysis
- Introductory video: Introduction to Matched Series Analysis
- Webinar: Beyond Matched Pairs: Applying Matsy to predict new optimisation strategies
- Tutorial: Matched Series Analysis
INTERESTED IN LEAD OPTIMISATION?
Discover StarDrop™
With its comprehensive suite of integrated software, StarDrop™ delivers best-in-class in silico technologies while retaining a highly visual, user-friendly interface. StarDrop™ enables a seamless flow from the latest data through predictive modelling to decision-making regarding the next round of synthesis and research, thus improving the speed, efficiency, and productivity of the drug discovery process.